Follow Flash Finance FollowTelegram

SRF Limited (SRF) — Multibagger Analysis

AI research on 1 Expansion / Order-win announcement by SRF Limited since October 2026 — deal magnitude, revenue and EPS impact, execution risk, and the actual return since each announcement measured from the next trading day's open and benchmarked against the Nifty Smallcap 250.

1
Announcements analysed
0
Strong candidates
54/100
Best multibagger score

Capacity addition

· Expansion · Possible · Chemicals · score 54/100
Deal
Deal value₹600 Cr
Deal vs business₹600 Cr capex is ~3.5% of TTM revenue (₹17,001 Cr) and ~4.7% of net worth (₹12,680 Cr), spread across 4 years.
Size vs own revenue0.04×
Execution period4.0 yr
Fundamental gradeA
AI projections
Revenue uplift (yr1 / steady)0.0% / 3.5%
EPS uplift3.8%
Upside base / bull / bear38.0% / 75.0% / -22.0%
Horizon24-48 months
Realized market record
Entry — next-day open (22 Oct 2026)₹2275.0
Latest close (02 Nov 2026)₹2409.0
Return since+5.9%
α vs Smallcap 250+5.1%
α vs own sectorshown once held 90+ days — Chemicals median is -3.0% over 81 matured picks
Positives
  • Strategic diversification into high-barrier EV battery supply chain (12,000 MTPA battery foil), mitigating exposure to cyclical packaging films.
  • Sharp operating recovery underway with Q1 FY27 consolidated PAT surging 75.5% YoY to ₹758.9 Cr and OPM expanding to 24.6%.
  • Strong balance sheet resilience (D/E of 0.27, Net Worth ₹12,680 Cr) allows funding the ₹600 Cr project via internal accruals and low-cost debt without dilution.
  • Brownfield expansion at existing Jaitpur (MP) site leverages established infrastructure and recently operational aluminium foil manufacturing capabilities.
Risks
  • Long execution gestation: Phase I commissioning is slated for September 2028 (24 months) and Phase II for September 2030 (48 months), yielding zero near-term revenue impact.
  • Demanding OEM qualification hurdles: Battery-grade foils require strict multi-year testing and qualification cycles from EV cell manufacturers before commercial offtake ramps up.
  • Persistent global chemical margin pressure driven by Chinese capacity dumping in fluorochemicals and BOPET/BOPP films.
  • Large-cap valuation base: At a market cap of ₹68,333 Cr and P/E of 31.6x, multi-fold returns require massive multi-year earnings compounding rather than quick re-rating.
Full AI brief

SRF Limited: Capex Evaluation & Multibagger Analysis

Analysis Date: 2026-10-21
Current Price: ₹2,305.0 | Market Cap: ₹68,333 Cr | P/E (TTM): 31.6x | ROCE: 16.0%


1. Ramp-Aware Catalyst Arithmetic

  • Announcement: Board approval for a ₹600 Cr capex to establish a 12,000 MTPA battery aluminium foil facility at Jaitpur, Madhya Pradesh via subsidiary SRF Altech Limited.
  • Execution Timeline: Split into two phases of ₹300 Cr each:
  • Phase I (6,000 MTPA): Commissioning target by September 30, 2028 (~24 months).
  • Phase II (6,000 MTPA): Commissioning target by September 30, 2030 (~48 months).
  • Revenue Potential at Steady-State:
  • Battery-grade foil commands realizations of ₹4,50,000 – ₹5,00,000 per MT.
  • Full 12,000 MTPA capacity implies steady-state annual revenue potential of ~₹550–600 Cr.
  • TTM Revenue context: ₹17,001 Cr. Thus, the project represents a ~3.2%–3.5% steady-state revenue addition.
  • Ramp Schedule:
  • Year 1 (FY27) & Year 2 (FY28): 0% uplift (under construction).
  • FY29 (Phase I Ramp): ~₹250–300 Cr revenue uplift (~1.5%–1.8%).
  • FY31 (Full Steady-State): ~₹570–600 Cr uplift (~3.5%).
  • EBITDA & EPS Flow-Through:
  • Assuming an operating margin of 22.0% (consistent with company-wide OPM of 22.5%), steady-state EBITDA addition is ~₹125–130 Cr.
  • Less depreciation (~₹40 Cr) and interest (~₹15 Cr), PBT adds ~₹70–75 Cr. At a 25% tax rate, net PAT accretion is ~₹55–60 Cr.
  • On a base TTM PAT of ₹2,162 Cr, steady-state EPS uplift is ~₹1.9–2.1/share (+2.7% to +3.8% on TTM EPS of ₹72.93).

2. Industry Capital Intensity & Expected CAGR

  • Capital Intensity: HIGH. Precision rolling of ultra-thin battery foils (typically sub-12 to 15 microns) requires high-end imported rolling mills and clean-room slitting environments.
  • Execution Difficulty: MEDIUM-HIGH. While SRF has operational experience from its recently commissioned general foil line, battery foil involves stringent metallurgy, defect tolerance, and long qualification lead times with battery cell manufacturers (gigafactories).
  • Structural CAGR: The EV and battery storage supply chain in India and export markets is expected to grow at >25% CAGR over the next decade. Overall blended specialty chemicals and industrial packaging expect a ~10–12% structural CAGR.

3. Fundamental Quality & Minervini SEPA Assessment

  • Earnings Acceleration: SRF is exhibiting a sharp cyclical turnaround. After a trough in FY25 (EPS ₹42.2), FY26 closed at ₹61.91 (+46.7%). Q1 FY27 consolidated net profit jumped 75.5% YoY to ₹758.9 Cr (EPS ₹25.6), and standalone Q2 FY27 PAT rose 20.9% YoY. Fundamental grade is A.
  • Balance Sheet Health: Net Debt/Equity is exceptionally conservative at 0.27 (Debt: ₹3,390 Cr vs Net Worth: ₹12,680 Cr). Operating cash flows comfortably support annual capex of ₹2,000+ Cr.
  • ROCE: Stood at 16.0% TTM, showing recovery from lower cyclical levels, though still below historical peak levels (>20%).
  • Promoter Holding: Completely stable at 50.26% with zero reported pledges or governance overhangs.

4. Valuation Context & Multi-Year Scenarios

  • Base Case (+38% Upside over 36 months):
  • Specialty fluorochemicals, refrigerants, and agro/pharma intermediates drive 16% CAGR PAT growth to ~₹3,400 Cr by FY29.
  • Battery foil Phase I commissions on schedule in late 2028.
  • Forward P/E multiple settles at ~27.5x (from trailing 31.6x), yielding an equity valuation of ~₹93,500 Cr (target price ~₹3,180).
  • Bull Case (+75% Upside over 36–48 months):
  • Rapid ramp-up in fluoropolymer partnership (Chemours), Chinese dumping subsides, and quick vendor qualification in battery foil delivers 22% PAT CAGR to ~₹4,000 Cr.
  • P/E expands to 30.0x, valuing the firm at ~₹120,000 Cr (target price ~₹4,030).
  • Bear Case (-22% Downside):
  • Prolonged Chinese overcapacity in basic refrigerants and packaging films dampens pricing power. Phase I faces delays and extended validation cycles.
  • Net profit plateaus near ₹2,200–2,400 Cr and P/E de-rates to 22.0x, yielding a target price around ~₹1,800.

5. Verdict Rationale

  • SRF is a high-grade industrial compounder with top-tier technical capability and capital discipline.
  • However, from a multibagger hunting perspective, the ₹600 Cr capex is an incremental bolt-on (~3.5% of sales) spread over four years, not a transformational trigger.
  • At a large-cap market capitalization of ₹68,333 Cr, a 3x–5x return within an intermediate horizon is structurally constrained by scale. The stock qualifies as POSSIBLE for steady 15–18% annual compounding, but not as an explosive short-to-medium term multibagger.
Analysis as of 2026-10-21 (price ₹2305.00) · AI research, not investment advice.
FollowTelegram

Verdicts and projections on this page are produced by an AI model from SRF Limited's public exchange filings and are not investment advice. "Return since" is measured from the opening price of the next trading day after each announcement to the latest available close, so it reflects a price an investor could actually have paid. See all analysed companies on Multibagger AI.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI